HIV/AIDS
ConjuChem
ConjuChem is working on both Type 2 Diabetes as well as HIV/AIDS.
Read Full Post | Make a Comment ( None so far )Tanox: AIDS, lymphoma, asthma, and more…
Tanox has a small but good-looking pipeline that covers AIDS, lymphoma, asthma, etc.
Read Full Post | Make a Comment ( None so far )Trimeris, working on HIV/AIDS
Trimeris is literally all about HIV/AIDS, but they’re not doing so well lately, having laid off many of its workers.
Read Full Post | Make a Comment ( None so far )The Immune Response Corporation canceling its HIV clinical trials.
Bad, bad news for the therapeutic HIV pipeline: The Immune Response Corporation, which had been developing Remune as a therapy for HIV/AIDS, has announced it has canceled its HIV clinical trials.
The company also announced it will rebrand itself to Orchestra Therapeutics in light of the changes.
Blogged with Flock
If true, the biggest breakthrough in HIV/AIDS, ever…
Yesterday, Sangamo Biosciences announced, “human immune system cells can be made permanently resistant to HIV infection by treatment with zinc finger DNA-binding protein nucleases” (Sangamo.com)
If this pans out in clinical trials, this will be amazing!
A slate of natural pharmaceutical products are in the works.
When it comes to nutritional supplements, most people equate “natural” to mean “good” and “safe,” but that’s not entirely true. The natural substance Ephedra, for instance, can be deadly. Still, the perception is based on somewhat-sound logic: if it’s found in natural substances, how could it be bad? The key really isn’t [...]
Read Full Post | Make a Comment ( 3 so far )Novel HIV treatment approaches.
The current HIV treatment approaches primarily rely on inhibiting viral HIV attachment/replication to and within healthy cells. There are a few novel approaches I’d like to note here.
Read Full Post | Make a Comment ( None so far )
